CDK 4/6 inhibition overcomes acquired and inherent resistance to pi3kα inhibition in pre‐clinical models of head and neck squamous cell carcinoma

Eric Remer, Mai Badarni, Elad Hikri, Avraham Dayan, Lirit Levi, Aron Popovtzer, Muhammed Iraqi, Angel Porgador, Ben Zion Joshua, Gideon Bachar, Moshe Elkabets, Maurizio Scaltriti, Aviram Mizrachi

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'CDK 4/6 inhibition overcomes acquired and inherent resistance to pi3kα inhibition in pre‐clinical models of head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science